Loading...

Vivos Inc.

RDGLPNK
Healthcare
Medical - Devices
$0.10
$0.008(8.42%)

Vivos Inc. (RDGL) Financial Performance & Income Statement Overview

Explore the financials of Vivos Inc. (RDGL), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
43.56%
43.56%
Operating Income Growth
6.77%
6.77%
Net Income Growth
-0.52%
0.52%
Operating Cash Flow Growth
-30.24%
30.24%
Operating Margin
-5882.76%
5882.76%
Gross Margin
-92.84%
92.84%
Net Profit Margin
-6433.29%
6433.29%
ROE
-144.60%
144.60%
ROIC
-113.62%
113.62%

Vivos Inc. (RDGL) Income Statement & Financial Overview

Explore comprehensive income reports for Vivos Inc. RDGL, broken down by year and quarter.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$4995.00$5000.00$13500.00$4500.00
Cost of Revenue$10280.00$3919.00$10780.00$97125.00
Gross Profit-$5285.00$1081.00$2720.00-$92625.00
Gross Profit Ratio-$1.06$0.22$0.20-$20.58
R&D Expenses$100969.00$66551.00$99662.00$57447.00
SG&A Expenses$555546.00$692275.00$334739.00$427057.00
Operating Expenses$656515.00$844226.00$525029.00$484504.00
Total Costs & Expenses$666795.00$848145.00$535809.00$581629.00
Interest Income$19612.00$17882.00$18851.00$18590.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$0.00$0.00$10780.00$577129.00
EBITDA-$661800.00-$843145.00-$511529.00$0.00
EBITDA Ratio-$132.49-$168.63-$37.89$0.00
Operating Income-$661800.00-$843145.00-$522309.00-$577130.00
Operating Income Ratio-$132.49-$168.63-$38.69-$128.25
Other Income/Expenses (Net)-$361388.00$17882.00$18852.00$18590.00
Income Before Tax-$1.02M-$825263.00-$503457.00-$558539.00
Income Before Tax Ratio-$204.84-$165.05-$37.29-$124.12
Income Tax Expense$0.00$0.00$0.00-$577129.00
Net Income-$1.02M-$825263.00-$503457.00-$558539.00
Net Income Ratio-$204.84-$165.05-$37.29-$124.12
EPS-$0.003-$0.002-$0.001-$0.001
Diluted EPS-$0.003-$0.002-$0.001-$0.001
Weighted Avg Shares Outstanding$420.85M$418.63M$403.38M$389.41M
Weighted Avg Shares Outstanding (Diluted)$420.85M$418.63M$403.38M$389.41M

Financial performance has remained strong, with revenue growing from $4500.00 in Q1 2024 to $4995.00 in Q4 2024. Gross profit continued to perform well, with margins at -106% in the latest quarter. Operating income reached -$661800.00 in Q4 2024, holding a steady -13249% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$661800.00. Net income dropped to -$1.02M, keeping EPS at -$0.003. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;